Robert W. Baird Has Lowered Expectations for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price target lowered by Robert W. Baird from $1,375.00 to $1,310.00 in a research note issued to investors on Monday morning,Benzinga reports. The firm currently has a neutral rating on the medical instruments supplier’s stock.

Several other brokerages also recently commented on MTD. Stifel Nicolaus upped their target price on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a research note on Monday, August 5th. Evercore ISI lifted their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company began coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $1,400.00 target price on the stock. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a report on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average price target of $1,338.75.

Mettler-Toledo International Price Performance

MTD stock opened at $1,239.13 on Monday. The company has a 50-day moving average of $1,388.91 and a two-hundred day moving average of $1,401.80. The stock has a market capitalization of $26.15 billion, a price-to-earnings ratio of 33.41, a price-to-earnings-growth ratio of 4.16 and a beta of 1.16. Mettler-Toledo International has a 52-week low of $1,039.01 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. Equities analysts expect that Mettler-Toledo International will post 40.37 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several large investors have recently added to or reduced their stakes in the stock. Capital International Investors boosted its position in shares of Mettler-Toledo International by 15.1% in the 1st quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after purchasing an additional 141,431 shares in the last quarter. PineStone Asset Management Inc. grew its stake in shares of Mettler-Toledo International by 127.4% during the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after purchasing an additional 145,453 shares during the period. Loomis Sayles & Co. L P raised its position in Mettler-Toledo International by 1.8% in the third quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after acquiring an additional 3,644 shares during the period. TD Asset Management Inc grew its holdings in Mettler-Toledo International by 1.9% during the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock valued at $219,767,000 after purchasing an additional 2,866 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its stake in Mettler-Toledo International by 32.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock worth $199,777,000 after acquiring an additional 35,048 shares during the period. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.